10x Genomics, Inc.
TXG
$61.65
$1.672.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.20% | 85.57% | 76.16% | 58.19% | 64.72% |
| Total Depreciation and Amortization | 18.36% | 4.69% | -8.05% | -13.82% | -18.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.80% | -22.73% | -20.69% | -22.88% | -21.65% |
| Change in Net Operating Assets | 473.95% | -94.57% | 1,888.76% | -74.69% | -160.30% |
| Cash from Operations | 89.82% | 125.27% | 1,941.57% | 126.00% | 961.12% |
| Capital Expenditure | 43.94% | 50.43% | 52.11% | 47.63% | 58.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.85% | 106.07% | 108.72% | -205.64% | -173.74% |
| Cash from Investing | 66.14% | 71.53% | 58.82% | -297.21% | -243.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -28.65% | -31.39% | -37.67% | -24.41% | -46.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -129.50% | -120.99% | -37.67% | -24.41% | -46.90% |
| Foreign Exchange rate Adjustments | -125.21% | 14,950.00% | 395.12% | -5.49% | 711.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 485.87% | 432.07% | 953.64% | -58.58% | -63.47% |